- Home
- ALVO vs EOS Comparison
ALVO vs EOS Comparison
Compare ALVO & EOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ALVO | EOS |
|---|---|---|
| Founded | 2013 | N/A |
| Country | Luxembourg | United States |
| Employees | 1032 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | N/A | 2004 |
Fundamental Metrics
Financial Performance| Metric | ALVO | EOS |
|---|---|---|
| Price | $3.62 | $20.76 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | ★ 605.3K | 132.3K |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $37.82 | N/A |
| Revenue Next Year | $25.80 | N/A |
| P/E Ratio | $18.20 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.03 | $17.56 |
| 52 Week High | $11.85 | $24.49 |
Technical Indicators
Market Signals| Indicator | ALVO | EOS |
|---|---|---|
| Relative Strength Index (RSI) | 47.47 | 47.35 |
| Support Level | $3.03 | N/A |
| Resistance Level | $4.17 | $24.35 |
| Average True Range (ATR) | 0.19 | 0.40 |
| MACD | 0.06 | 0.05 |
| Stochastic Oscillator | 70.00 | 64.37 |
Price Performance
Historical ComparisonAbout ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.
About EOS Eaton Vance Enhance Equity Income Fund II
Eaton Vance Enhanced Equity Income Fund II is a diversified, closed-end management investment company. The fund's primary investment objective is to provide current income, with a secondary objective of capital appreciation. Under normal market conditions, the Fund invests at least 80% of its total assets in common stocks. It invests in a portfolio of large and mid-cap securities in sectors such as Information Technology, Consumer Discretionary, Communication Services, Healthcare, Industrials, Consumer Staples, Financials, Materials, and Energy.